日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy

ATR 抑制剂 AZD6738 的给药方案可以增强或消除放射治疗的抗肿瘤免疫反应

Frank P Vendetti, Pinakin Pandya, David A Clump, Sandra Schamus-Haynes, Meysam Tavakoli, Maria diMayorca, Naveed M Islam, Jina Chang, Greg M Delgoffe, Jan H Beumer, Christopher J Bakkenist

Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression

胸苷可挽救ATR激酶抑制剂诱导的基因组DNA中脱氧尿苷污染、细胞死亡和干扰素-α/β表达。

Norie Sugitani ,Frank P Vendetti ,Andrew J Cipriano ,Pinakin Pandya ,Joshua J Deppas ,Tatiana N Moiseeva ,Sandra Schamus-Haynes ,Yiyang Wang ,Drake Palmer ,Hatice U Osmanbeyoglu ,Anna Bostwick ,Nathaniel W Snyder ,Yi-Nan Gong ,Katherine M Aird ,Greg M Delgoffe ,Jan H Beumer ,Christopher J Bakkenist

p53 Promotes Cytokine Expression in Melanoma to Regulate Drug Resistance and Migration

p53 促进黑色素瘤中的细胞因子表达来调节耐药性和迁移

Pinakin Pandya, Lyubov Kublo, Jacob Stewart-Ornstein

PICOT binding to chromatin-associated EED negatively regulates cyclin D2 expression by increasing H3K27me3 at the CCND2 gene promoter

PICOT 与染色质相关 EED 结合,通过增加 CCND2 基因启动子处的 H3K27me3 来负向调节细胞周期蛋白 D2 的表达

Pinakin Pandya, Minesh Jethva, Eitan Rubin, Ramon Y Birnbaum, Alex Braiman, Noah Isakov